AR and prostate cancer: For example, trimethylation of histone H3 lysine 9 (H3K9me3) catalyzed by SUV39H1 promotes heterochromatin at the androgen receptor variant 7 (AR-V7) promoter in prostate cancer, sustaining AR-V7 expression and conferring resistance to enzalutamide [149].